Your browser doesn't support javascript.
COVID-19: Clinical features, case fatality, and the effect of symptoms on mortality in hospitalized cases in Iran.
Alimohamadi, Yousef; Sepandi, Mojtaba; Rashti, Roya; Sedighinezhad, Homeira; Afrashteh, Sima.
  • Alimohamadi Y; Exercise Physiology Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Sepandi M; Department of Epidemiology and Biostatistics, School of Public Health, Baqiyatallah University of Medical Sciences, Iran.
  • Rashti R; Exercise Physiology Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Sedighinezhad H; Department of Epidemiology and Biostatistics, School of Public Health, Baqiyatallah University of Medical Sciences, Iran.
  • Afrashteh S; School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
J Taibah Univ Med Sci ; 17(5): 725-731, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-1945865
ABSTRACT

Objective:

Identifying the epidemiological characteristics of COVID-19 could help to control the pandemic. The aim of this study was to characterize the epidemiological features of hospitalized COVID-19 patients in Iran.

Methods:

Data were collected on patients admitted to a military referral hospital in Tehran, Iran, from February 8, 2020 to July 28, 2021. Sex, age, clinical symptoms, outcome, type of comorbidities, level of blood Spo2, time of admission, and time of discharge were investigated. Sex ratio, case fatality rate (CFR), and daily trends of hospital admissions and deaths were also determined. Descriptive statistics and multiple logistic regression with 95% confidence intervals were used for data analysis. The statistical significance level was set at 0.05. STATA16.0 and Excel 2010 were used for data analysis.

Results:

The median hospital length of stay (LOS) was 6 days. The following symptoms were most common cough (63.5%), fever (50%), respiratory distress (46.1%), and muscular pain (40.8%). Hypertension (29.5%), diabetes (24.7%), and cardiovascular diseases (21.8%) were the most prevalent comorbidities. The CFR was calculated at 8.30%. Respiratory symptoms increased the odds of death by 45% (OR 1.45, 95% CI 1.03-2.06). Gastrointestinal symptoms were associated with a reduction in the mortality of COVID-19 cases, but this association was not statistically significant (OR 0.94, 95% CI 0.73-1.21).

Conclusions:

The results of this study emphasize higher mortality rates among older age groups, male patients, and patients with underlying diseases.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: J Taibah Univ Med Sci Year: 2022 Document Type: Article Affiliation country: J.jtumed.2022.04.010

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: J Taibah Univ Med Sci Year: 2022 Document Type: Article Affiliation country: J.jtumed.2022.04.010